CINDY ORDONEZ: Open Payments
NPI 1417618547 · RANCHO CUCAMONGA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,751 in 240 payments from 18 companies in 2025. Trend: 2023 $2,013 · 2024 $2,823 · 2025 $4,751
Food & beverage: $4,730Education: $21
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 39 | $740 |
| ABBVIE INC. | 35 | $645 |
| Teva Pharmaceuticals USA, Inc. | 23 | $436 |
| Neurocrine BioSciences, Inc. | 18 | $412 |
| Corium, LLC | 16 | $370 |
| Janssen Pharmaceuticals, Inc | 13 | $361 |
| E.R. Squibb & Sons, L.L.C. | 15 | $342 |
| Axsome Therapeutics, Inc. | 20 | $341 |
| Alkermes, Inc. | 13 | $260 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $228 |
Products named: REXULTI, VRAYLAR, INGREZZA, Azstarys, INVEGA SUSTENNA, COBENFY, Auvelity, ARISTADA.
Industry payments across CA — which companies pay providers there.
